2112.HK
Get informed when a big investor buys or sells
+ Follow| Market cap | $58.50 Million |
|---|---|
| Enterprise Value | $220.26 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.01 |
| Beta | -0.86 |
| Outstanding Shares | 1,500,000,000 |
| P/E Ratio | -0.27 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.04 |
| Enterprise Value to Revenue | 8.81 |
| Enterprise Value to EBIT | -5.76 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.73 |
| Debt to Equity | -0.84 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Grace Life-tech Holdings Limited, an investment holding company, engages in the research, development, and application of plant stem cell technology. It is also involved in the provision of health solutions and product sales in Hong Kong...